Formed and preformed metabolites: Facts and comparisons

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 10, 2008, Pages 1247-1275

  Pang, K Sandy ^a,b   Morris, Marilyn E ^a   Sun, Huadong ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ALAFOSFALIN; BENZOIC ACID; BETAMETHASONE; CAPECITABINE; CARINDACILLIN; CYCLOSPORIN; DIAZEPAM; DRUG METABOLITE; ENALAPRIL; ESTRONE SULFATE; ETACRYNIC ACID; FOSFOMYCIN; FOSINOPRIL; IRINOTECAN; LEVODOPA; LISDEXAMFETAMINE; MEVINOLIN; MIDAZOLAM; MORPHINE; NUCLEOSIDE TRANSPORTER; PARACETAMOL; SULFOTRANSFERASE; TACROLIMUS; TALAGLUMETAD; UNINDEXED DRUG; VALACICLOVIR; VALGANCICLOVIR; VALTORCITABINE; ZIDOVUDINE;

BIOLOGICAL MODEL; DRUG EFFECT; DRUG ELIMINATION; DRUG EXPOSURE; DRUG METABOLISM; DRUG STRUCTURE; INTESTINE; KIDNEY; LIVER; ORGAN PERFUSION; REVIEW; SIMULATION;

EID: 52949140158     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.10.0001     Document Type: Review

References (238)

1. Aboul-Enein, H. Y., Schauberger, C. W., Hansen, A. R., Fischer, L. J. (1975) Synthesis of an active hydroxylated glutethimide metabolite and some related analogs with sedative-hypnotic and anticonvulsant properties. J. Med. Chem. 18: 736-741
2. Abu Zahra, T. N., Pang, K. S. (2000) Effect of zonal transport and metabolism on hepatic removal: enalapril hydrolysis in zonal, isolated rat hepatocytes in vitro and correlation with perfusion data. Drug Metab. Dispos. 28: 807-813
3. Agus, D. B., Gambhir, S. S., Pardridge, W. M., Spielholz, C., Baselga, J., Vera, J. C., Golde, D. W. (1997) Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J. Clin. Invest. 100: 2842-2848
4. Aldini, R., Montagnani, M., Roda, A., Hrelia, S., Biagi, P. L., Roda, E. (1996) Intestinal absorption of bile acids in the rabbit. Different transport rates in jejunum and ileum. Gastroenterology 110: 459-468
5. Alvarez-Diez, T. M., Zheng, J. (2004) Detection of glutathione conjugates derived from 4-ipomeanol metabolism in bile of rats by liquid chromatography-tandem mass spectrometry. Drug Metab. Dispos. 32: 1345-1350
6. Anundi, I. M., Kauffman, F. C., El-Mouelhi, M., Thurman, R. G. (1986) Hydrolysis of organic sulfates in periportal and pericentral regions of the liver lobule: studies with 4-methylumbelliferyl sulfate in the perfused rat liver. Mol. Pharmacol. 29: 599-605
7. Arancibia, A., Gai, M. N., Chávez, J., Paulos, C., Pinilla, E., González, C., Villanueva, S., Ritschel, W. A. (2005) Pharmacokinetics of prednisolone in man during acute and chronic exposure to high altitude. Int. J. Clin. Pharmacol. Ther. 43: 85-91
8. Baillie, T. A., Cayen, M. N., Founda, H., Gerson, R. J., Green, J. D., Grosman, S. J., Klunk, L. J., LeBlanc, B., Perkins, D. G., Shipley, L. A. (2002) Contemporary issues in toxicology. Drug metabolites in safety. Toxicol. Appl. Pharmacol. 182: 188-196
9. Banks, A. T., Zimmerman, H. J., Ishak, K. G., Harter, J. G. (1995) Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the Food and Drug Administration as adverse reactions. Hepatology 22: 820-827
10. Baron, J., Redick, J. A., Guengerich, F. P. (1978) Immunohistochemical localizations of cytochromes P-450 in rat liver. Life Sci. 23: 2627-2632
11. Baron, J., Redick, J. A., Guengerich, F. P. (1980) Immunohistochemical localization of epoxide hydratase in rat liver. Life Sci. 26: 489-493
12. Baron, J., Redick, J. A., Guengerich, F. P. (1981) An immunohistochemical study on the localization and distributions of phenobarbital- and 3-methylcholanthrene-inducible cytochromes P-450 within the livers of untreated rats. J. Biol. Chem. 256: 5931-5937
13. Barry, M. G., Khoo, S. H., Veal, G. J., Hoggard, P. G., Gibbons, S. E., Wilkins, E. G., Williams, O., Breckenridge, A. M., Back, D. J. (1996) The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites. AIDS 10: 1361-1367
14. Barter, Z. E., Bayliss, M. K., Beaune, P. H., Boobis, A. R., Carlie, D. J., Edwards, R. J., Houston, J. B., Lake, B. G., Lipscomb, J. C., Pelkonen, O. R., Tucker, G. T., Rostami-Hodjegan, A. (2007) Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values on human microsomal protein and hepatocellurity per gram of liver. Curr. Drug Metab. 8: 33-45
15. Bengtsson, G., Julkunen, A., Penttilä, K. E., Lindros, K. O. (1987) Effect of phenobarbital on the distribution of drug metabolizing enzymes between periportal and perivenous rat hepatocytes prepared by digitonin-collagenase liver perfusion. J. Pharmacol. Exp. Ther. 240: 663-667
16. Benowitz, N. L., Meister, W. (1978) Clinical pharmacokinetics of lignocaine. Clin. Pharmacokinet. 3: 177-201
17. Blick, S. K., Keating, G. M. (2007) Lisdexamfetamine. Paediatr. Drugs 9: 129-135; discussion 136-128
18. Boom, S. P., Moons, M. M., Russel, F. G. (1994) Renal tubular transport of cimetidine in the isolated perfused kidney of the rat. Drug Metab. Dispos. 22: 148-153
19. Boxenbaum, H. (1982) Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J. Pharmacokinet. Biopharm. 10: 201-227
20. Boxenbaum, H., Ronfeld, R. (1983) Interspecies pharmacokinetic scaling and the Dedrick plots. Am. J. Physiol. 245: R768-R775
21. Boyd, M. R., Burka, L. T., Wilson, B. J., Sasame, H. A. (1978) In vitro studies on the metabolic activation of the pulmonary toxin, 4-ipomeanol, by rat lung and liver microsomes. J. Pharmacol. Exp. Ther. 207: 677-686
22. Breimer, D. D., Jochemsen, R., von Albert, H. H. (1980) Pharmacokinetics of benzodiazepines. Short-acting versus long-acting. Arzneimittelforschung 30: 875-881
23. Brown, F., Banken, L., Saywell, K., Arum, I. (1999) Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers. Clin. Pharmacokinet. 37: 167-176
24. Bu, H.-Z., Kang, P., Deese, A. J., Zhao, P., Pool, W. F. (2005) Human in vitro glutathionyl and protein adducts of carbamazepine-10,11-epoxide, a stable and pharmacologically active metabolite of carbamazepine. Drug Metab. Dispos. 33: 1920-1924
25. Bueno, A. B., Collado, I., de Dios, A., Dominguez, C., Martin, J. A., Martin, L. M., Martinez-Grau, M. A., Montero, C., Pedregal, C., Catlow, J., Coffey, D. S., Clay, M. P., Dantzig, A. H., Lindstrom, T., Monn, J. A., Jiang, H., Sehoepp, D. D., Stratford, R. E., Tabas, L. B., Tizzano, J. P., Wright, R. A., Herin, M. F. (2005) Dipeptides as effective prodrugs of the unnatural amino acid (+)-2-aminobicyclo-[3.1.0]hexane-2.6-dicarboxylic acid (LY354740). a selective group II metabotropic glutamate receptor agonist. J. Med. Chem. 48: 5305-5320
26. Chan, K. K., Bolger, M. K., Pang, K. S. (1985) Statistical moment theory in chemical kinetics. Analyt. Chem. 11: 2145-2151
27. Chang, J. H., Kochansky, C. J., Magang, S. (2006) The role of P-glycoprotein in the bioactivation of raloxifene. Drug Metab. Dispos. 34: 2073-2078
28. Chen, J., Pang, K. S. (1997) Effect of flow on first-pass metabolism of drugs: single pass studies on 4-methylumbelliferone (4MU) conjugation in the serially perfused rat intestine and liver preparations. J. Pharmacol. Exp. Ther. 280: 24-31
29. 3 via the vitamin D receptor (VDR). Mol. Pharmacol. 69: 1913-1923
30. Chen, Q., Doss, G. A., Tung, E. C., Liu, W., Tang, Y. S., Braun, M. P., Didolkar, V., Strauss, J. R., Wang, R. W., Stearns, R. A., Evans, D. C., Baillie, T. A., Tang W. (2006b) Evidence for the bioactivation of zomepirac and tolmetin by an oxidative pathway: identification of glutathione adducts in vitro in human liver microsomes and in vivo in rats. Drug Metab. Dispos. 34: 145-151
31. Chiba, M., Poon, K., Hollands, J., Pang, K. S. (1994) Glycine conjugation activity of benzoic acid and its acinar localization in the perfused rat liver. J. Pharmacol. Exp. Ther. 268: 409-416
32. Cong, D., Doherty, M., Pang, K. S. (2000) A new physiologically-based segregated flow model to explain route-dependent intestinal metabolism. Drug Metab. Dispos. 28: 224-235
33. Cong, D., Fong, A. K. Y., Lee, R., Pang, K. S. (2001) Absorption of benzoic acid (BA) by segmental regions of the in situ perfused rat small intestine. Drug Metab. Dispos. 29: 1539-1547
34. Connolly, S. J., Kates, R. E. (1982) Clinical pharmacokinetics of N-acctylprocainamide. Clin. Pharmaeokinet. 7: 206-220
35. Conway, J. G., Kauffman, F. C., Ji, S., Thurman, R. G. (1982) Rates of sulfation and glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the liver lobule. Mol. Pharmacol. 22: 509-516
36. Conway, J. G., Kauffman, F. C., Tsukada, T., Thurma, R. G. (1984) Glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the liver lobule. Mol. Pharmacol. 25: 487-493
37. Cundy, K. C., Annamalai, T., Bu, L., De Vera, J., Estrela, J., Luo, W., Shirsat, P., Torneros, A., Yao, F., Zou, J., Barrett, R. W., Gallop, M. A. (2004) XP13512 [(+/-)-1-([(alpha-isobutanoyl-oxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys. J. Pharmacol. Exp. Ther. 311: 324-333
38. Dahan, A., van Dorp, E., Smith, T., Yassen, A. (2008) Morphine-6-glucuronide (M6G) for postoperative pain relief. Eur. J. Pain 12: 403-411
39. Dahlin, D. C., Miwa, G. T., Lu, A. Y., Nelson, S. D. (1984) N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc. Natl. Acad. Sci. USA 81: 1327-1331
40. Dalpiaz, A., Pavan, B., Scaglianti, M., Vitali, F., Bortolotti, F., Biondi, C., Scatturin, A., Manfredini, S. (2005) Vitamin C and 6-amino-vitamin C conjugates of diclofenac: synthesis and evaluation. Int. J. Pharm. 291: 171-181
41. Davis-Bruno, K. L., Atrakchi, A. (2006) A regulatory perspective on issues and approaches in characterizing human metabolites. Chem. Res. Toxicol. 19: 1561-1563
42. Dawson, J. R., Weitering, J. G., Mulder, G. J., Stillwell, R. N., Pang, K. S. (1985) Alteration of transit time and direction of flow to probe the heterogeneous distribution of conjugating activities for harmol in the perfused rat liver preparation. J. Pharmacol. Exp. Ther. 234: 691-697
43. De Buck, S. S., Sinha, V. K., Fenu, L. A., Nijsen, M. J., Mackie, C. E., Gilissen, R. A. H. J. (2007) Prediction of human pharmacokinetics using physiologically based modeling: A retrospective analysis of 26 clinically tested drugs. Drug Metab. Dispos. 35: 1766-1780
44. de Lannoy, I. A. M. Pang, K. S. (1986) Presence of a diffusional barrier on metabolite kinetics: enalaprilat as a generated versus preformed metabolite. Drug Metab. Dispos. 14: 513-520
45. de Lannoy, I. A. M, Pang, K. S. (1987) Effect of diffusional barriers on drug and metabolite kinetics. Drug Metab. Dispos. 15: 51-58
46. de Lannoy, I. A. M., Pang, K. S (1993) Combined recirculation of the rat liver and kidney: Studies with enalapril and enalaprilat. J. Pharmacokinet. Biopharm. 21: 423-456
47. de Lannoy, I. A. M., Barker, F. 3rd, Pang, K. S. (1993) Formed and preformed metabolite excretion clearances in liver, a metabolite formation organ: studies on enalapril and enalaprilat in the single-pass and recirculating perfused rat liver. J. Pharmaeokinet. Biopharm. 21: 395-422
48. Deguchi, T., Kouno, Y., Terasaki, T., Takadate, A., Otagiri, M. (2005) Differential contributions of rOat1 (S1c22a6) and rOat3 (S1c22a8) to the in vivo renal uptake of uremic toxins in rats. Pharm. Res. 22: 619-627
49. Desmoulin, F., Gilard, V., Malet-Martino, M., Martino, R. (2002) Metabolism of capecitabine, an oral fluorouracil prodrug: (19)F NMR studies in animal models and human urine. Drug Metab. Dispos. 30: 1221-1229
50. Doherty, M., Pang, K. S. (2000) Route-dependent metabolism of morphine in the vascularly perfused rat small intestine preparation. Pharm. Res. 17: 290-297
51. Doherty, M., Poon, K., Tsang, C., Pang, K. S. (2006) Transport is not rate-limiting in morphine glucuronidation in the single pass perfused rat liver preparation. J. Pharmacol. Exp. Ther. 317: 890-900
52. Drayer, D. E. (1976) Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure. Clin. Pharmaeokinet. 1: 423-443
53. Dubey, R. K., Singh, J. (1988a) Localization and characterization of drug-metabolizing enzymes along the villus-crypt surface of the rat small intestine I. Monooxyenases. Biochem. Pharmacol. 37: 169-176
54. Dubey, R. K., Singh, J. (1988b) Localization and characterization of drug-metabolizing enzymes along the villus-crypt surface of the rat small intestine II. Conjugases. Biochem. Pharmacol. 37: 177-184
55. Ducharme, M. P., Warbasse, L. H, Edwards. D. J. (1995) Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin. Pharmacol. Ther. 57: 485-491
56. Ebner, T., Heinzel, G., Prox, A., Beschke, K., Wachsmuth, H. (1999) Disposition and chemical stability of telmisartan 1-O-acylglucuronide. Drug Metab. Dispos. 27: 1143-1149
57. Edwards, C. R., Stewart, P. M. (1991) The cortisol-cortisone shuttle and the apparent specificity of glucocorticoid and mineralocorticoid receptors. J. Steroid. Biochem. Mol. Biol. 39: 859-865
58. El Mouelhi, M., Kauffman, F. C. (1986) Sublobular distribution of transferases and hydrolases associated with glucuronide, sulfate and glutathione conjugation in human liver. Hepatologx 6: 450-456
59. Englund, G., Rorsman, F., Rönnblom, A., Karlbom, U., Lazorova, L., Gråsjö, J., Kindmark, A., Artursson, P. (2006) Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells. Eur. J. Pharm. Sci. 29: 269-277
60. Ezra, A., Hoffman, A., Breuer, E., Alferiev, I. S., Monkkonen, J., El Hanany-Rozen, N., Weiss, G., Stepensky, D., Gati, I., Cohen, H., Tormalehto, S., Amidon, G. L., Golomb, G. (2000) A peptide prodrug approach for improving bisphosphonate oral absorption. J. Med. Chem. 43: 3641-3652
61. Falany, C. N., Kerl, E. A. (1990) Sulfation of minoxidil by human liver phenol sulfotransferase. Biochem. Pharmacol. 40: 1027-1032
62. Fan, P. W., Bolton, J. L. (2001) Bioactivation of tamoxifen to metabolite E quinone methide: reaction with glutathione and DNA. Drug Metab. Dispos. 29: 891-896
63. FDA guidance for Industry. Safety testing of drug metabolites. February 2008 Pharmcology and Toxicology. www.fda.gov/cder/guidance/
64. Fei, Y. J., Kanai, Y., Nussberger, S., Ganapathy, V., Leibach, F. H., Romero, M. F., Singh, S. K., Boron, W. F., Hediger, M. A. (1994) Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature 368: 563-566
65. Friedman, D. I., Amidon, G. L. (1989) Passive and carrier-mediated intestinal absorption components of two angiotensin converting enzyme (ACE) inhibitor prodrugs in rats: enalapril and fosinopril. Pharm. Res. 6: 1043-1047
66. Friedrichsen, G. M., Chen, W., Begtrup, M., Lee, C. P., Smith, P. L., Borchardt, R. T. (2002) Synthesis of analogs of L-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells. Eur. J. Pharm. Sci. 16: 1-13
67. Fujino, H., Saito, T., Ogawa, S., Kojima, J. (2005) Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase. J. Pharm. Pharmacol. 57: 1305-1311
68. Funk, C., Pantze, M., Jehle, L., Ponelle, C., Scheuermann, G., Lazendic, M., Gasser, R. (2001) Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate. Toxicology 167: 83-98
69. Gandhi, M. D., Kansara, V., Mitra, A. K. (2005) Oral disposition of ganciclovir amino acid ester prodrugs: intestinal absorption and transport. AAPS J. 7: R6247
70. Geng, W., Pang, K. S. (1999) Differences in excretion of hippurate, as a metabolite of benzoate and as an administered species, in the single pass isolated perfused rat kidney explained. J. Pharmacol. Exp. Ther. 288: 597-606
71. Geng, W. P., Schwab, A. J., Goresky, C. A., Pang, K. S. (1995) Carrier-mediated uptake and excretion of bromosulfophthalein-glutathione in perfused rat liver: A multiple indicator dilution study. Hepatology 22: 1188-1207
72. Geng, W., Schwab, A. J., Horie, T., Goresky, C. A., Pang, K. S. (1998) Hepatic uptake of bromosulfophthalein-glutathione in perfused EHBR mutant liver: A multiple indicator dilution study. J. Pharmacol. Exp. Ther. 284: 480-492
73. Gill, R. K., Saksena, S., Alrefai, W. A., Sarwar, Z., Goldstein, J. L., Carroll, R. E., Ramaswamy, K., Dudeja, P. K. (2005) Expression and membrane localization of MCT isoforms along the length of the human intestine. Am. J. Physiol. 289: 846-852
74. Gillette, J. R. (1980) Pharmacokinetic factors governing the steady-state concentrations of foreign chemicals and their metabolites. Ciba Found. Symp. 76: 191-217
75. Gopaul, S. V., Farrell, K., Abbott F. S. (2000) Identification and characterization of N-acetylcysteine conjugates of valproic acid in humans and animals. Drug Metab. Dispos. 28: 823-832
76. Goresky, C. A., Pang, K. S., Schwab, A. J., Barker, F. 3rd, Cherry, W. F., Bach, G. G. (1992) Uptake of a protein-bound polar compound, acetaminophen sulfate, by perfused rat liver. Hepatology 15: 173-190
77. Goresky, C. A., Bach, G. G., Schwab, A. J. (1993a) Distributed-in-space product formation in vivo: linear kinetics. Am. J. Physiol. 264: H2007-H2028
78. Goresky, C. A., Bach, G. G., Schwab, A. J. (1993b) Distributed-in-space product formation in vivo: enzymic kinetics. Am. J. Physiol. 264: H2029-H2050
79. Gotoh, Y., Suzuki, H., Kinoshita, S., Hirohashi, T., Kato, Y., Sugiyama, Y. (2000) Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/ multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats. J. Pharmacol. Exp. Ther. 292: 433-439
80. Gramatté, T. (1996) Griseofulvin absorption from different sites in the human small intestine. Biopharm. Drug Dispos. 15: 747-759
81. Gramatté, T., El Desoky, E., Klotz, U. (1994) Site-dependent small intestinal absorption of ranitidine. Eur. J. Clin. Pharmacol. 46: 253-259
82. Gramatté, T., Oertel, R., Terhaag, B., Kirch, W. (1996) Direct demonstration of small intestinal secretion and site-dependent absorption of the beta-blocker talinolol in humans. Clin. Pharmacol. Ther. 59: 541-549
83. Grappel, S. F., Giovenella, A. J., Nisbet,. L. J. (1985) Activity of a peptidyl prodrug, alafosfalin, against anaerobic bacteria. Antimicrob. Agents Chemother. 27: 961-963
84. Grillo, M. P., Hua, F. (2003) Identification of zomepirac-S-acyl- glutathione in vitro in incubations with rat hepatocytes and in vivo in rat bile. Drug Metab. Dispos. 31: 1429-1436
85. Grillo, M. P., Knutson, C. G., Sanders, P. E., Waldon, D. J., Hua F., Ware, J. A. (2003) Studies on the chemical reactivity of diclofenac acyl glucuronide with glutathione: identification of diclofenac-S-acyl- glutathione in rat bile. Drug Metab. Dispos. 31: 1327-1336
86. +/bile acid cotransporter. J. Clin. Invest. 93: 1326-1331
87. Halifax, D., Houston, J. B. (2006) Binding of drugs to hepatic microsomes: comments and assessment of current prediction methodology with recommendation for improvement. Drug Metab. Dispos. 34: 724-726
88. Han, H., de Vrueh, R. L., Rhie, J. K., Covitz, K. M., Smith, P. L., Lee, C. P., Oh, D. M., Sadee, W., Amidon, G. L. (1998) 5′-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm. Res. 15: 1154-1159
89. He, K., Talaat, R. E., Pool, W. F., Reily, M. D., Reed, J. E., Bridges, A. J., Woolf, T. F. (2004) Metabolic activation of troglitazone: identification of a reactive metabolite and mechanisms involved. Drug Metab. Dispos. 32: 639-646
90. Herrmann, M. (2003) Salicylic acid: an old dog, new tricks, and staphylococcal disease. J. Clin. Invest. 112: 149-151
91. Himmelstein, M. W., Carpenter, S. C. Evans, M. V., Hinderliter, P. M., Kenyon, E. M. (2004) Modeling of b-chloroprene metabolism: II. The application of physiologically based modelling for cancer dose response analysis. Toxicol. Sci. 79: 28-37
92. Hirani, V. N., Raucy, J. L., Lasker, J. M. (2004) Conversion of the HIV protease inhibitor nelfinavir to a bioactive metabolite by human liver CYP2C19. Drug Metab. Dispos. 32: 1462-1467
93. Ho, R. H., Tirona, R. G., Leake, B. F., Glaeser, H., Lee, W., Lemke, C. J., Wang, Y., Kim, R. B. (2006) Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology 130: 1793-1806
94. Hoensch, H., Woo, C. H., Schmid, R. (1975) Cytochrome P450 and drug metabolism in intestinal villous and crypt cells of rats. Effects of dietary iron. Biochem. Biophys. Res. Commun. 65: 399-406
95. Homma, H., Tada, M., Nakamura, T., Yamagata, S., Matsui, M. (1997) Heterogeneous zonal distribution of sulfotransferase isoenzymes in rat liver. Arch. Biochem. Biophys. 339: 235-241
96. Ingelman-Sundberg, M., Johansson, I., Penttilä, K. E., Glaumann, H., Lindros, K. O. (1988) Centrilobular expression of ethanol-inducible cytochrome P-450 (IIE1) in rat liver. Biochem. Biophys. Res. Commun. 157: 55-60
97. Ishizawa, T., Sadahiro, S., Hosoi, K., Tamai, I., Terasaki, T., Tsuji, A. (1992) Mechanisms of intestinal absorption of the antibiotic, fosfomycin, in brush-border membrane vesicles in rabbits and humans. J. Pharmacobiodyn. 15: 481-489
98. Ishizuka, H., Konno, K., Naganuma, H., Nishimura, K., Kouzuki, H., Suzuki, H., Stieger, B., Meier, P. J., Sugiyama, Y. (1998) Transport of temocaprilat into rat hepatocytes: role of organic anion transporting polypeptide. J. Pharmacol. Exp. Ther. 287: 37-42
99. Ito, K., Houston, J. B. (2004) Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes. Pharm. Res. 21: 785-792
100. Ito, K., Houston, J. B. (2005) Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches. Pharm. Res. 22: 103-112
101. Jacquemin, E., Hagenbuch, B., Stieger, B., Wolkoff, A. W., Meier, P. J. (1994) Expression cloning of a rat liver Na(+)-independent organic anion transporter. Proc. Natl Acad. Sci. USA 91: 133-137
102. Jones, R. N. (1995) Cefotaxime and desacetylcefotaxime antimicrobial interactions. The clinical relevance of enhanced activity: a review. Diagn Microbiol. Infect. Dis. 22: 19-33
103. Jones, H. M., Parrott, N., Jorga, K., Lavé, T. (2006) A novel strategy for physiologicallly based predictions of human pharmacokinetics. Clin. Pharmacokinet. 45: 511-542
104. Jordan, V. C., Collins, M. M., Rowsby, L., Prestwich, G. (1977) A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity. J. Endocrinol. 75: 305-316
105. Joulin, D., Blanchard, N., Alexandre, E., Delobel, F., Savid-Pierson, P., Lavé, T., Jaeck, D., Richert, L., Coassolo, P. (2006) Cryopreserved human hepatocytes in suspension are a convenient high throughput tool for the prediction of metabolic clearance. Eur. J. Pharm. Sci. Biopharm. 63 : 347-355
106. Kalgutkar, A. S., Vaz, A. D. N., Lame, M. E., Henne, K. R., Soglia, J., Zhao, S. X., Abramov, Y. A., Lombardo, F., Collin, C., Hendsch, Z. S., Hop, C. E. (2005) Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinoneimine species in human liver microsomes and recombinant cytochrome P450 3A4. Drug Metab. Dispos. 33: 243-253
107. Kawai, R., Mathew D., Tanaka, C., Rowland, M. (1998) Physiologically based pharmacokinetics of cyclosporin A: extension to tissue distribution kinetics in rats and scale up to human. J. Pharmacol. Exp. Ther. 287: 457-468
108. Kera, Y., Sippel, H. W., Penttilä, K. E., Lindros, K, O. (1987) Acinar distribution of glutathione-dependent detoxifying enzymes. Low glutathione peroxidase activity in perivenous hepatocytes. Biochem. Pharmacol. 36: 2003-2006
109. Kido, Y., Tamai, 1., Okamoto, M., Suzuki, F., Tsuji, A. (2000) Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier using in vitro cultured cells and in vivo BUI studies. Pharm. Res. 17: 55-62
110. Klippert, P. J., Noordhoek, J. (1985) The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Its dependence on the administration route of precursor drug. Drug Metab. Dispos. 13: 97-101
111. Knapp, S. A., Green, M. D., Tephly, T. R., Baron, J. (1988) Immunohistochemical demonstration of isozyme- and strain-specific differences in the intralobular localizations and distributions of UDP- glucuronosyltransferases in livers of untreated rats. Mol. Pharmacol. 33: 14-21
112. Koster, H., Halsema, I., Pang, K. S., Scholtens, E., Mulder, G. J. (1982) Kinetics of sulfation and glucuronidation of harmol in the perfused rat liver preparation. Disappearance of aberrancies in glucuronidation kinetics by inhibition of sulfation. Biochem. Pharmacol. 31: 3023-3038
113. Koster, A. S., Frankhuijzen-Sierevogel, A. C., Noordhoek, J. (1985) Glucuronidation of morphine and six β2-sympathominetics in isolated rat intestinal epithelial cells. Drug Metab. Dispos. 13: 232-237
114. Kullak-Ublick, G. A., Glasa, J., Boker, C., Oswald, M., Grutzner, U., Hagenbuch, B., Stieger, B., Meier, P. J., Beuers, U., Kramer, W., Wess, G., Paumgartner, G. (1997) Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas. Gastroenterology 113: 1295-1305
115. Lampen, A., Christians, W., Guengerich, F. P., Watkins, P. B., Kolars, J., Bader, A., Gonschior, A.-K., Dralle, H., Hackbarth, I., Sewing, K.-F. (1995) Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions and interindividual variability. Drug Metab. Dispos. 23: 1315-1324
116. Lash, L. H., Fisher, J. W., Lipscomb, J. C., Parker, J. C. (2000) Metabolism of trichloroethylene. Environ. Health Perspect. 108 (Suppl 2): 177-200
117. Li, Y. H., Ito, K., Tsuda, Y., Kohda, R., Yamada, H., Itoh, T. (1999) Mechanism of intestinal absorption of an orally active betalactam prodrug: uptake and transport of carindacillin in Caco-2 cells. J. Pharmacol. Exp. Ther. 290: 958-964
118. Li, L. Y., Amidon, G. L., Kim, J. S., Heimbach, T., Kesisoglou, F., Topliss, J. T., Fleisher, D. (2002) Intestinal metabolism promotes regional differences in apical uptake of indinavir: coupled effect of P-glycoprotein and cytochrome P450 3A on indinavir membrane permeability. J. Pharmacol. Exp. Ther. 301: 586-593
119. Lim, Y. C., Desta, Z., Flockhart, D. A., Skaar, T. C. (2005) Endoxifen (4-hydroxy-N-desmethyltamoxifen) has antiestrogenic effects in breast cancer cells with potency similar to 4-hydroxytamoxifen. Cancer Chemother. Pharmacol. 55: 471-478
120. Lin, J. H., Chiba, M., Baillie, T. A. (1999) Is the role of the small intestine in first-pass metabolism overemphasized? Pharmacol. Rev. 51: 135-158
121. Liu, L., Pang, K. S. (2006) An integrated approach to model hepatic-drug clearance. Eur. J. Pharm. Sci. 29: 215-230
122. Liu, L., Mak, E., Tirona, R. G., Tan, E., Novikoff, P. M, Wang, P. J., Wolkoff, A. W., Pang, K. S. (2005) Vascular binding, blood flow, transporter, and enzyme interactions on the processing of digoxin in rat liver. J. Pharmacol. Exp. Ther. 315: 433-448
123. Liu, S., Tarn, D., Chen, X., Pang, K. S. (2006) P-glycoprotein and an unstirred water layer barring digoxin absorption in the vascularly perfused rat small intestine preparation: induction studies with pregnenolone-16alpha- carbonitrile. Drug Metab. Dispos. 34: 1468-1479
124. Majumdar, S., Duvvuri, S., Mitra, A. K (2004) Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development. Adv. Drug Deliv. Rev. 56: 1437-1452
125. McGinnity, D. F., Soars, M. G, Urbanowicz, R. A., Riley, R. J. (2004) Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance. Drug Metab. Dispos. 32: 1247-1253
126. McGuire, J. L., Phillips, A., Hahn, D. W., Tolman, E. L., Flor, S., Kafrissen, M. E. (1990) Pharmacologic and pharmacokinetic characteristics of norgestimate and its metabolites. Am. J. Obstet. Gynecol. 163: 2127-2131
127. Mizuno, N., Niwa, T., Yotsumoto, Y., Sugiyama, Y. (2003) Impact of drug transporter studies on drug discovery and development. Pharmacol. Rev. 55: 425-461
128. Morris M. E., Pang, K. S. (1987) Competition between two enzymes for substrate removal in liver: modulating effects of competitive pathways. J. Pharmacokinet. Biopharm. 15: 473-496
129. Morris, M. E., Yuen, V., Tang, B. K. Pang, K. S. (1988a) Competing pathways in drug metabolism. I. Effect of input concentration on the conjugation of gentisamide in the once-through in situ perfused rat liver preparation. J. Pharmacol. Exp. Ther. 245: 614-624
130. Morris, M. E., Yuen, V., Pang, K. S. (1988b) Competing pathways in drug metabolism. II. An identical, anterior enzymatic distribution for 2- and 5-sulfoconjugation and a posterior localization for 5-glucuronidation of gentisamide in the rat liver. J. Pharmacokinet. Biopharm. 16: 633-656
131. Mottino, A. D., Hoffman, T., Jennes, L., Vore, M. (2000) Expression and localization of multidrug resistant protein mrp2 in rat small intestine. J. Pharmacol. Exp. Ther. 293: 717-723
132. Nelson, S. D., Mitchell, J. R., Timbrell, J. A., Snodgrass, W. R., Corcoran, G. B. 3rd (1976) Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat. Science 193: 901-903
133. Nestorov, I. A., Aarons, L. J., Arundel, P. A., Rowland, M. (1998) Lumping of whole-body physiologically-based pharmacokinetic models. J. Pharmcokinet. Biopharm. 26: 21-46
134. Ngo, L. Y., Patil, S. D., Unadkat, J. D. (2001) Ontogenic and longitudinal activity of Na+-nucleoside transporters in the human intestine. Am. J. Physiol. 280: G475-G481
135. Nozawa, T., Minami, H., Sugiura, S., Tsuji, A., Tamai, I (2005) Role of organic anion transporter OATP1BC (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecan: in vitro evidence and effect of single nucleotide polymorphism. Drug Metab. Dispos. 33: 434-439
136. Nybsäck, H. V., Walters, J. R., Aghajanian, G. K., Roth, R. H. Tricyclic antidepressants: effects on the firing rate of brain noradrenergic neurons. Eur. J. Pharmacol. 32: 302-312
137. Obach, R. S. (1999) Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab. Dispos. 27: 1350-1359
138. Oinonen, T., Lindros, K. O. (1995) Hormonal regulation of the zonated expression of cytochrome P-450 3A in rat liver. Biochem. J. 309: 55-61
139. Oitate, M., Hirota, T., Murai, T., Miura, S., Ikeda, T. (2007) Covalent binding of rofecoxib, but not other cyclooxygenase-2 inhibitors, to a lysine aldehyde in elastin of human aorta. Drug Metab. Dispos. 35: 1846-1852
140. Olsen, J., Li, C., Skonberg, C., Bjørnsdottir, I., Sidenius, U., Benet, L. Z., Hansen, S. H. (2007) Studies on the metabolism of tolmetin to the chemically reactive acyl-coenzyme a thioester intermediate in rats. Drug Metab. Dispos. 35: 758-764
141. Olson, R. D., Mushlin, P. S., Brenner, D. E., Fleischer, S., Cusack, B. J., Chang, B. K., Boucek, R. I. Jr. (1988) Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol. Proc. Natl Acad. Sci. USA 85: 3585-3589
142. Paine, M. F., Shen, D. D., Kunze, K. L., Perkins, J. D., Marsh, C. L., McVicar, J. P., Barr, D. M., Gilles, B. S., Thummel, K. E. (1996) First-pass metabolism of midazolam by the human intestine. Clin. Pharmacol. Ther. 60: 14-24
143. Paine, M. F., Khalighi, M., Fisher, J. M., Shen, D. D., Kunze, K. L., Marsh, C. L., Perkins, J. D., Thummel, K. E. (1997) Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J. Pharmacol. Exp. Ther. 283: 1552-1562
144. Pang, K. S. (1985a) A review of metabolite kinetics. J. Pharmacokinet. Biopharm. 13: 632-662
145. Pang, K. S. (1985b) A modern view of metabolite kinetics. In: Barnett, G., Chiang, C. N. (eds) Pharmacokinetics and pharmacodynamics of psychoactive drugs. A Research Monograph. Biomedical Publications, Foster City, pp 323-379
146. Pang, K. S. (1995) Modeling of metabolite disposition. In: D'Argenio, D. Z. (ed) Advanced methods of pharmacokinetic and pharmacodynamic system analysis, volume 11. Plenum Press, New York, pp 3-26
147. Pang, K. S. (2003) Modeling of intestinal drug absorption. Roles of transporters and metabolic enzymes (for the Gillette Series). Drug Metab. Dispos. 31: 1507-1519
148. Pang, K. S., Gillette, J. R. (1978) Kinetics of metabolite formation and elimination in the perfused rat liver preparation: differences between the elimination of preformed cetaminophen and acetaminophen formed from phenacetin. J. Pharmacol. Exp. Ther. 207: 178-194
149. Pang, K. S., Gillette, J. R. (1979) Sequential first-pass elimination of a metabolite derived from a precursor. J. Pharmacokinet. Biopharm. 7 275-290
150. Pang, K. S., Kwan, K. C. (1983) A Commentary. Methods and assumptions in
151. Erratum (1984) Drug Metab. Dispos. 12: 674
152. Pang, K. S., Terrell, J. A. (1981a) Retrograde perfusion to probe the heterogeneous distribution of hepatic drug metabolizing enzymes in rats. J. Pharmacol. Exp. Ther. 216: 339-346
153. Pang, K. S., Terrell, J. A. (1981b) Conjugation kinetics of acetaminophen by the perfused rat liver preparation. Biochem. Pharmacol. 30: 1959-1965
154. Pang, K. S., Koster, H., Halsema, I. C. M., Scholtens, E., Mulder, G. J. (1981) Aberrant pharmacokinetics of harmol in the perfused rat liver preparation: Sulfate and glucuronide conjugations. J. Pharmacol. Exp. Ther. 219: 134-140
155. Pang, K. S., Koster, H., Halsema, I. C. M., Scholtens, E., Mulder, G. J., Stillwell, R. N. (1983) Normal and retrograde perfusion to probe the zonal distribution of sulfation and glucuronidation activities of harmol in the perfused rat liver preparation. J. Pharmacol. Exp. Ther. 224: 647-653
156. Pang, K. S., Kong, P., Terrell, J. A., Billings, R. E. (1985a) Metabolism of acetaminophen and phenacetin by isolated rat hepatocytes: a system in which the spatial organization inherent in the liver is disrupted. Drug Metab. Dispos. 13: 42-50
157. Pang, K. S., Cherry, W. F., Ulm, E. H. (1985b) Disposition of enalapril in the perfused rat intestine-liver preparation: Absorption, metabolism, and first-pass effects. J. Pharmacol. Exp. Ther. 233: 788-795
158. Pang, K. S., Fayz, S., Yuen, V., te Koppele, J., Mulder, G. J (1986) Absorption and metabolism of acetaminophen by the in situ perfused rat small intestine preparation. Drug Metab. Dispos. 14: 102-113
159. Pang, K. S., Cherry, W. F., Accaputo, J., Schwab, A. J., Goresky, C. A. (1988) Combined hepatic arterial-portal venous and hepatic arterial-hepatic venous perfusions to probe the abundance of drug metabolizing activities: perihepatic venous O-deethylation activity for phenacetin and periportal sulfation activity for acetaminophen in the once-through rat liver preparation. J. Pharmacol. Exp. Ther. 247: 690-700
160. Pang, K. S., Barker, F. 3rd, Cherry, W. F., Goresky, C. A. (1991) Esterases for enalapril hydrolysis are concentrated in the perihepatic venous region of the rat liver. J. Pharmacol. Exp. Ther. 257: 294-301
161. Pang, K. S., Barker, F. 3rd, Simard, A., Schwab, A. J., Goresky, C. A. (1995) Sulfation of acetaminophen by the perfused rat liver: Effect of red blood cell carriage. Hepatologv 22: 267-282
162. Pang, K. S., Wang, P. J., Chung, A. F. Wolkoff, A. W. (1998a) The modified dipeptide enalapril, an angiotensin converting enzyme (ACE) inhibitor, is transported by the rat liver organic anion transport protein (oatp1). Hepalology 28: 1341-1346
163. Pang, K. S., Geng, W., Schwab, A. J. Goresky, C. A. (1998b) Probing the structure and function of the liver with the multiple indicator dilution technique. In: Bassingthwaigthe, J., Goresky, C. A., Lenihan, J. N. (eds) Whole organ approach to cellular metabolism: capillary permeation, cellular transport and reaction kinetics. Springer-Verlag, pp 325-368
164. Parrott, N., Jones, H., Paquerau, N., Lavé, T. (2005) Application of full physiological models for pharmaceutical drug candidate selection and extrapolation of pharmacokinetics to man. Basic Clin. Pharmacol. Toxicol. 96: 193-199
165. Pearce, R. E., Uetrecht, J. P., Leeder, J. S. (2005) Pathways of carbamazepine bioactivation in vitro: ii. the role of human cytochrome P450 enzymes in the formation of 2-hydroxyiminostilbene. Drug Metab. Dispos. 33: 1819-1826
166. Petzinger, E., Nickau, L., Horz, J. A., Schulz, S., Wess, G., Enhsen, A., Falk, E., Baringhaus, K. H., Glombik, H., Hoffmann, A., Mülliner, S., Neckermann, G., Kramer, W. (1995) Hepatobiliary transport of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors conjugated with bile acids. Hepatologv 22: 1801-1811
167. Pierra, C., Amador, A., Benzaria, S., Cretton-Scott, E., D'Amours, M., Mao, J., Mathieu, S., Moussa, A., Bridges, E. G., Standring, D. N., Sommadossi, J. P. , Storer, R., Gosselin, G. (2006) Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2′-C-methylcytidine. J. Med. Chem. 49:6614-6620
168. Pinkus, L. M., Ketley, J. N., Jakoby, W. B. (1977) The glutathione S-transferases as a possible detoxification system of rat intestinal epithelium. Biochem. Pharmacol. 26: 2359-2363
169. Polhuijs, M., Meijer, D. K., Mulder, G. J. (1991) The fate of diastereomeric glutathione conjugates of alpha-bromoisovalerylurea in blood in the rat in vivo and in the perfused liver. Stereoselectivity in biliary and urinary excretion. J. Pharmacol. Exp. Ther. 256: 458-461
170. Polhuijs, M., Gasinska, I., Cherry, W. F., Mulder, G. J., Pang, K. S. (1993) Stereoselectivity in glutathione conjugation and amidase catalyzed hydrolysis of the 2-bromoisovalerylurea enantiomers in the single pass perfused rat liver. J. Pharmacol. Exp. Ther. 265: 1402-1412
171. Polt, R., Porreca, F., Szabo, L. Z., Bilsky, E. J., Davis, P., Abbruscato, T. J., Davis, T. P., Harvath, R., Yamamura, H. I., Hruby,V. J. (1994) Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier. Proc. Natl Acad. Sci. USA 91: 7114-7118
172. Poon, G. K., Chen, Q., Teffera, Y., Ngui, J, S., Griffin, P. R., Braun, M. P., Doss, G. A., Freeden, C., Stearns, R. A., Evans, D. C., Baillie, T. A., Tang, W. (2001) Bioactivation of diclofenac via benzoquinone imine intermediates - identification of urinary mercapturic acid derivatives in rats and humans. Drug Metab. Dispos. 29: 1608-1613
173. Poulin, P., Theil, F.-P. (2002a) Prediction of pharmacokinetics prior to in vivo studies. I. Mechanism-based prediction of volume of distribution. J. Pharm. Sci. 91: 129-156
174. Poulin, P., Theil, F.-P. (2002b) Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition. J. Pharm. Sci. 91: 1358-1370
175. Rappaport, A. M (1958) The structural and functional unit in the human liver (liver acinus). Anat. Rec. 130: 673-689
176. Ratna, S., Chiba, M., Bandyopadhyay, L., Pang, K. S. (1993) Futile cycling between 4-methylumbelliferone and its conjugates in perfused rat liver. Hepatology 17: 838-853
177. Redick, J. A., Jakoby, W. B., Baron, J. (1982) Immunohistochemical localization of glutathione S-transferases in livers of untreated rats. J. Biol. Chem. 257: 15200-15203
178. Riley, R. J., McGinnity, D. F., Austin, R. P. (2005) A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes. Drug Metab. Dispos. 33: 1304-1311
179. Robertson, D., Tung, C. S., Goldberg, M. R., Hollister, A. S., Gerkens, J. F., Oates, J. A. (1984) Antihypertensive metabolites of alpha-methyldopa. Hypertension 6: 1145-50
180. Rost, D., Mahner, S., Sugiyama, Y., Stremmel, W. (2002) Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine. Am. J. Physiol. 282: G720-G726
181. Sakaeda, T., Siahaan, T. J., Audus, K. L., Stella, V. J. (2000) Enhancement of transport of D-melphalan analogue by conjugation with L-glutamate across bovine brain microvessel endothelial cell monolayers. J. Drug Target. 8: 195-204
182. Samtani, M. N., Lohle, M., Grant, A., Nathanielsz, P. W., Jusko, W. J. (2005) Betamethasone pharmacokinetics after two prodrug formulations in sheep: implications for antenatal corticosteroid use. Drug Metab. Dispos. 33: 1124-1130
183. Sato, T., Neschadim, A., Konrad, M., Fowler, D. H., Lavie, A., Medin, J. A. (2007) Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy. Mol. Ther. 15: 962-970
184. Sawada, Y., Haraschima. H., Hanano, M., Sugiyama, Y., Iga, T. (1985) Prediction of plasma concentration-time courses of various drugs in humans based on data from rats. J. Pharmacohiodyn. 8: 757-766
185. Schwab, A. J., Pang, K. S. (2000) The multiple indicator dilution method and its utility in risk assessment. Environ. Health Perspect. 108 (Suppl 5): 1-15
186. Schwab, A. J., Tao, L., Yoshimura, T., Simard, A., Barker, F., Pang, K. S. (2001) Hepatic uptake and metabolism of benzoate: A multiple indicator dilution, perfused rat liver study. Am. J. Physiol. 280: G1124-G1136
187. Schwarz, L. R., Schwenk, M. (1984) Sulfation in isolated enterocytes of guinea pig: dependence of inorganic sulfate. Biochem. Pharmacol. 33: 3353-3356
188. Shin, H. C., Kim, J. S., Vig, B. S., Song, X., Drach, J. C., Amidon, G. L. (2006) Interaction of intestinal nucleoside transporter hCNT2 with amino acid ester prodrugs of floxuridine and 2-bromo-5,6-dichloro-1-beta-D- ribofuranosylbenzimidazole. Biol. Pharm. Bull. 29: 247-252
189. 14C in rats. Chem. Pharm. Bull. 21: 2031-2038
190. Shitara, Y., Li., A. P., Kato, Y., Lu, C., Ito, K., Itoh, T., Sugiyama, Y. (2003) Function of uptake transporters for taurocholate and estradiol 17β-D-glucuronide in cryopreserved human hepatocytes. Drug Metab. Pharmacokinet. 18: 33-41
191. Shneider, B. L., Dawson, P. A., Christie, D. M., Hardikar, W., Wong, M. H., Suchy, F. J. (1995) Cloning and molecular characterization of the ontogeny of a rat ileal sodium-dependent bile acid transporter. J. Clin. Invest. 95: 745-754
192. Simmonds, A. C., Reilly, C. A., Baldwin, R. M., Ghanayem, B. I., Lanza, D. L., Yost, G. S., Collins, K. S., Forkert P.-G. (2004) Bioactivation of 1,1-dichloroethylene to its epoxide by CYP2E1 and CYP2F enzymes. Drug Metab. Dispos. 32: 1032-1039
193. Sirianni, G. L., Pang, K. S. (1997) Organ clearance concepts: New perspectives on old principles. J. Pharmacokinet. Biopharm. 25: 457-478
194. Smith, D. A., Obach, R. S. (2005) Commentary. Seeing through the MIST: Abundance versus percentage, commentary on metabolites in safety testing. Drug Metab. Dispos. 33: 1409-1417
195. Smith, D. A., Obach, R. S. (2006) Metabolites and safety: What are the concerns, and how should we address them? Chem. Res. Toxicol. 19: 1570-1579
196. Smith, N. F., Figg, W. D., Sparreboom, A. (2005) Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination. Expert Opin. Drug Metab. Toxicol. 1: 429-445
197. Snel, C. A. W., Zhao, Y., Mulder, G. J., Pang, K. S. (1993) Methods for the quantitation of bromosulfophthalein and its glutathione conjugate in biological fluids. Analyt. Biochem. 212: 28-34
198. Soars, M. G., Burhcell, B., Riley, R. J. (2002) In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance. J. Pharmacol. Exp. Ther. 301: 382-390
199. Somers, G. I., Lindsay, N., Lowdon, B. M., Jones, A. E., Freathy, C., Ho, S., Woodrooffe, A. J. M., Bayliss, M. K., Manchee, G. R. (2007) A comparison of the expression and metabolizing activities of phase I and II enzymes in freshly isolated human lung parenchymal cells and cryopreserved human hepatocytes. Drug Metab. Dispos. 35: 1797-1805
200. Stanley, L. A., Mills, I. G., Sim, E. (1997) Localization of polymorphic N-acetyltransferase (NAT2) in tissues of inbred mice. Pharmacogenetics 7: 121-130
201. Stickney, J. L. (1978) Effect of autonomic blocking agents on chronotropic actions of 1-alpha-acetylmethadol. Arch. Int. Pharmacodyn. Ther. 231: 70-80
202. St-Pierre, M. V., Xu, X., Pang, K. S. (1988) Primary, secondary, and tertiary metabolite kinetics. J. Pharmacokinet. Biopharm. 16: 493-527
203. St-Pierre, M. V., Pang, K. S (1993a) Kinetics of sequential metabolism. I. Formation and metabolism of oxazepam from nordiazepam and temazepam in the perfused murine liver. J. Pharmacol. Exp. Ther. 265: 1429-1436
204. St-Pierre, M. V., Pang, K. S. (1993b) Kinetics of sequential metabolism of metabolites. II. Formation and metabolism of nordiazpeam and oxazepam from diazepam in the perfused murine liver. J. Pharmacol. Exp. Ther. 265: 1437-1445
205. Sun, H., Liu, L., Pang, K. S. (2006) Increased estrogen sulfation of estradiol 17β-D glucuronide in metastatic rat tumor livers. J. Pharmacol. Exp. Ther. 319: 818-831
206. Sun, H., Pang, K. S. (2008) Disparity in intestine disposition between formed and preformed metabolites: A theoretical study. Drug Metab. Dispos., under review
207. Tabata, T., Katoh, M., Tokudome, S., Hosakawa, M., Chiba, K., Nakajima, M., Yokoi, T. (2004) Bioactivation of capecitabine in human liver: involvement of the cytosolic enzyme on 5 -deoxy-5-fluorocytidine formation. Drug Metab. Dispos. 32: 762-767
208. Tarn, D., Tirana, R. G., Pang, K. S. (2003) Segmental intestinal transporters and metabolic enzymes on intestinal drug absorption. Drug Metab. Dispos. 31: 373-383
209. Tamai, I., Sai, Y., Ono, A., Kido, Y., Yabuuchi, H., Takanaga, H., Satoh, E., Ogihara, T., Amano, O., Izeki, S., Tsuji, A. (1999) Immunohistochemical and functional characterization of pH-dependent intestinal absorption of weak organic acids by the monocarboxylic acid transporter MCT1. J. Pharm. Pharmacol. 51: 1113-1121
210. Tan, E., Pang, K. S. (2001) Sulfation is rate-limiting in the futile cycling between estrone and estrone sulfate in enriched periportal and perivenous rat hepatocytes. Drug Metab. Dispos. 29: 335-346
211. Tan, E., Lu, T., Pang, K. S. (2001) Futile cycling of estrone sulfate and estrone in the recirculating, perfused rat liver. J. Pharmacol. Exp. Ther. 297: 423-436
212. Tang, W. (2003) The metabolism of diclofenac - enzymology and toxicology perspectives. Curr. Drug Metab. 4: 319-329
213. Thummel, K. E., O'Shae, D., Paine, M. F., Shen, D. D., Kunze, K. L., Perkins, J. D., Wilkinson, G. R. (1996) Oral first pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism. Clin. Pharmacol. Ther. 59: 491-502
214. Tirona, R.G., Pang, K. S. (1996) Sequestered endoplasmic reticulum space for sequential metabolism of salicylamide: Coupling of hydroxylation and glucuronidation. Drug Metab. Dispos. 24: 821-833
215. Tirona, R. G., Tan, E., Meier, G., Pang, K. S. (1999) Uptake and glutathione conjugation of ethacrynic acid and efflux of the glutathione adduct by periportal and perivenous rat hepatocytes. J. Pharmacol. Exp. Ther. 291: 1210-1219
216. Tsuji, A. (1999) Tissue selective drug delivery utilizing carrier-mediated transport systems. J. Control. Release 62: 239-244
217. Tsuji, A., Tamai, I. (1996) Carrier-mediated intestinal transport of drugs. Pharm. Res. 13: 963-977
218. Uno, H., Cappas, A., Brigham, P. (1987) Action of topical minoxidil in the bald stump-tailed macaque. J. Am. Acad. Dermatol. 16: 657-668
219. van de Water, F. M., Masereeuw, R., Russel, F. G. (2005) Function and regulation of multidrug resistance proteins (MRPs) in the renal elimination of organic anions. Drug Metab. Rev. 37: 443-471
220. van Gelder, J., Deferme, S., Naesens, L., De Clercq, E., van den Mooter, G., Kinget, R., Augustijns, P. (2002) Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures. Drug Metab. Dispos. 30: 924-930
221. van Montfoort, J. E., Hagenbuch, B., Groothuis, G. M. M., Koepsell, H., Meier, P. J., Meijer, D. K.(2003) Drug uptake systems in liver and kidney. Curr. Drug Metab. 4: 185-211
222. Vickers, S., Duncan, C. A., Chen, I. W., Rosegay, A., Duggan, D. E. (1990) Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug. Drug Metab. Dispos. 18: 138-145
223. Wade, D. N., Mearrick, P. T., Morris, J. L. (1973) Active transport of L-dopa in the intestine. Nature 242: 463-465
224. Walters, H. C., Craddock, A. L., Fusegawa, H., Willingham, M. C., Dawson, P. A. (2000) Expression, transport properties, and chromosomal location of organic anion transporter subtype 3. Am. J. Physiol. 279: G1188-G1200
225. Wang, M., Dickinson, R. G. (1998) Disposition and covalent binding of diflunisal and diflunisal acyl glucuronide in the isolated perfused rat liver. Drug Metab. Dispos. 26: 98-100
226. Waninger, S., Ramos, S., Robbins, J. (2007) Combinations of thiovir and neuraminidase inhibitors exert synergistic antiviral activity on human, equine and avian influenza in vitro. Antiviral Res. 74: A82
227. Wen, Y., Remmel, R. P., Zimmerman, C. L. (1999) First-pass disposition of (-)-6-aminocarbovir in rats. I. Prodrug activation may be limited by access to enzyme. Drug Metab. Dispos. 27: 113-121
228. Wilcox, R. A., Owen, H. (2000) Variable cytochrome P450 2D6 expression and metabolism of codeine and other opioid prodrugs: implications for the Australian anaesthetist. Anaesth. Intensive Care 228: 611-669
229. Williams, J. G., Hallett, M. B. (1989) Effect of sulphasalazine and its active metabolite, 5-amino-salicylic acid, on toxic oxygen metabolite production by neutrophils. Gut 30: 1581-1587
230. Wong, M. H., Oelkers, P., Craddock, A. L., Dawson, P. A. (1994) Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter. J. Biol. Chem. 269: 1340-1347
231. Wong, H., Dockens, R. C., Pajor, L., Yeola, S., Grace, J. E. Jr., Stark, A. D., Taub, R. A., Yocca, F. D., Zaczek, R. C., Li. Y.-W. (2007) 6-Hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamine 1A receptor occupancy in rats Drug Metab. Dispos. 35: 1387-1392
232. Xie, M., Yang, D., Wu, M., Xue. B., Yan, B. (2003) Mouse liver and kidney carboxylesterase (M-LK) rapidly hydrolyzes antitumor prodrug irinotecan and the N-terminal three quarter sequence determines substrate selectivity. Drug Metab. Dispos. 31: 21-27
233. Xu, X., Pang, K. S. (1989) Hepatic modeling of metabolite kinetics in sequential and parallel pathways: salicylamide and gentisamide metabolism in perfused rat liver. J. Pharmacokinet. Biopharm. 17: 645-671
234. Xu, X., Tang, B. K., Pang, K. S. (1990) Sequential metabolism of salicylamide exclusively to gentisamide-5-glucuronide and not gentisamide sulfate conjugates in single pass in situ perfused rat liver. J. Pharmacol. Exp. Ther. 253: 963-973
235. Xu, X., Schwab, A. J. Barker F. 3rd. Goresky, C. A., Pang, K. S. (1994) Salicylamide sulfate cell entry in perfused rat liver: A multiple indicator dilution study. Hepatology 19: 229-244
236. Yamada, A., Maeda, K., Kamiyama, E., Sugiyama, D., Kondo, T., Shiroyanagi, Y., Nakazawa, H., Okano, T., Adachi, M., Schuetz, J. D., Adachi, Y., Hu, Z., Kusuhara, H., Sugiayama, Y. (2007) Multiple isoforms of drug transporters contributed to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor. Drug Metab. Dispos. 35: 2166-2176
237. Zhang, D., Ogan, M., Gedamke. R., Roongta, V., Dai, R., Zhu, M., Rinehart, J. K., Klunk, L., Mitroka, J. (2003) Protein covalent binding of maxipost through a cytochrome P450-mediated ortho-quinonc methide intermediate in rats. Drug Metab. Dispos. 31: 837-845
238. Zhao, Y., Snel, C. A., Mulder, G. J., Pang, K. S. (1993) Localization of glutathione conjugation activities toward bromosulfophthalein in perfused rat liver. Studies with the multiple indicator dilution technique. Drug Metab. Dispos. 21: 1070-1078